報價延遲最少15分鐘:2024/04/27 15:46 EDT
|
|
|
|
|
||||||||||||
|
|
|
|
|
1.72 
|
|
|
| 價值評估 |
|
盈利(現時/預測)
-9.16/-5.85
|
|
企業價值
19.20M
|
| 資產負債 |
|
每股賬面淨值
-6.20
|
| 現金流量 |
|
現金流量率
--
|
| 損益表 |
|
收益
2.45M
|
|
每股收益
0.09
|
|
同行比較
|
||||||||||||||||||||||||||||||||||||||||||||||||
|
報價延遲最少15分鐘：2024/04/27 15:46 EDT
同行比較之報價最少15分鐘延遲
|
業務概覽
|
|||
| PAVmed Inc is a multi-product, commercial-stage medical technology company organized to advance a broad pipeline of medical technologies from concept to commercialization. The Company operates in a single segment as a medical technology company, with the following lines of business: Diagnostics, Medical Devices, and Digital Health. Its products are EsoGuard, esocheck, and the Veris Cancer Care Platform. |